Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MRI Coverage Policies Reconsidered By US Medicare Agency

Executive Summary

CMS has opened a national coverage analysis for MRI, but the agency does not provide many details as to what prompted the coverage review or what changes it might consider making to covered or noncovered MRI indications.

You may also be interested in...



Medicare MRI Restrictions Removed For Cardiac Device Patients

The US Centers for Medicare and Medicaid Services followed through with a plan to expand its national coverage policy for MRI scans, removing contraindications and clinical-study requirements for patients with pacemakers, implantable cardioverter defibrillators and other cardiac rhythm devices.

Market Advantage Of 'MR-Conditional' Device Labeling Fades

Abbott Laboratories and Boston Scientific recently logged approvals that bring the firms closer to parity with Medtronic in being able to market their cardiac rhythm management devices as compatible with MRI scans. But CMS, the US Medicare agency, is currently considering a coverage policy that make so-called "MR-conditional" product labeling less significant.

Physicians Push For Less Restricted MRI Coverage For Pacemaker-Implanted Patients

Physician groups are expressing overwhelming support for CMS' proposal to cover magnetic resonance imaging in patients with FDA-approved MRI-safe pacemakers, and some are pushing for the agency to go much further.

Topics

UsernamePublicRestriction

Register

MT105161

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel